Related Experiment Video
Updated: May 6, 2026
Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
Published on: February 21, 2016
Donor pre-treatment in clinical kidney transplantation: a critical appraisal
Dorottya K de Vries1, Leonie G M Wijermars, Marlies E J Reinders
1Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Abstract:
Kidney transplantation represents one of the medical achievements of the 20th century. However, its continued success is limited by the increasing shortage of donor grafts. As a result, more kidney grafts from marginal donors are being considered for transplantation, with concomitantly more initial graft injury and limited organ and patient survival. This has led to an increased need for interventions aiming to optimize and preserve graft quality. Interventions within the donor may protect against ischemia/reperfusion injury, and therefore, donor pre-treatment is a promising strategy to increase graft function and survival. During the last decade, diverse donor pre-treatment interventions have been explored in animal studies. Moreover, the first human trials concerning donor pre-treatment in kidney transplantation have provided encouraging results. Unfortunately, it remains difficult to determine how and where to intervene in the multifactorial and complex processes that affect the donor kidney. Moreover, ethical matters play a critical role in donor interventions, and pre-treatment should principally not have any potentially unfavorable effects on other organs to be transplanted or on the living donor. This review provides an overview of promising therapeutical strategies for donor pre-treatment in kidney transplantation and discusses the clinical trials that have been conducted thus far.
Insights
Donor pre-treatment strategies show promise for improving kidney transplant graft quality and survival. Research is exploring interventions to protect against ischemia/reperfusion injury, with early human trials yielding encouraging results.
Area of Science:
- Nephrology
- Transplantation Immunology
- Surgical Innovation
Background:
- Kidney transplantation is a major 20th-century medical advance.
- Graft shortages necessitate using marginal donor kidneys, increasing initial injury and reducing survival.
- Optimizing graft quality through donor pre-treatment is crucial for better outcomes.
Purpose of the Study:
- To review promising therapeutic strategies for donor pre-treatment in kidney transplantation.
- To discuss the current landscape of clinical trials for donor pre-treatment.
- To highlight challenges and ethical considerations in donor intervention.
Main Methods:
- Review of diverse donor pre-treatment interventions explored in animal studies.
- Analysis of early-stage human clinical trials on donor pre-treatment for kidney transplantation.
- Discussion of multifactorial processes affecting donor kidneys and ethical implications.
Main Results:
- Animal studies demonstrate potential benefits of various donor pre-treatment interventions.
- Initial human trials for donor pre-treatment in kidney transplantation have shown encouraging results.
- Challenges remain in identifying optimal intervention points and ensuring donor safety.
Conclusions:
- Donor pre-treatment is a promising strategy to mitigate ischemia/reperfusion injury and enhance kidney graft function.
- Further research and clinical trials are needed to refine donor pre-treatment protocols.
- Ethical considerations and potential effects on the donor and other organs must be carefully evaluated.
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:26Kidney Transplant II: Surgical Procedure
01:16Kidney Transplant III: Nursing Management
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...